➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Last Updated: March 7, 2021

DrugPatentWatch Database Preview

EFFIENT Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Effient, and what generic alternatives are available?

Effient is a drug marketed by Daiichi Sankyo Inc and is included in one NDA.

The generic ingredient in EFFIENT is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.

Drug patent expirations by year for EFFIENT
Drug Prices for EFFIENT

See drug prices for EFFIENT

Drug Sales Revenue Trends for EFFIENT

See drug sales revenues for EFFIENT

Recent Clinical Trials for EFFIENT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gyeongsang National University HospitalPhase 4
U&I CorporationPhase 4
Janssen, LPPhase 4

See all EFFIENT clinical trials

Pharmacology for EFFIENT
Paragraph IV (Patent) Challenges for EFFIENT
Tradename Dosage Ingredient NDA Submissiondate
EFFIENT TABLET;ORAL prasugrel hydrochloride 022307 2013-07-10

US Patents and Regulatory Information for EFFIENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 AB RX Yes No   Start Trial   Start Trial   Start Trial
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-002 Jul 10, 2009 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EFFIENT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009   Start Trial   Start Trial
Daiichi Sankyo Inc EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-002 Jul 10, 2009   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for EFFIENT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0542411 C300397 Netherlands   Start Trial PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225
0542411 300397 Netherlands   Start Trial 300397, 20120909, EXPIRES: 20170908
0542411 CA 2009 00024 Denmark   Start Trial
0542411 09C0031 France   Start Trial PRODUCT NAME: PRASUGREL; NAT. REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225; FIRST REGISTRATION: EU/1/08/503/001/-014 20090225
0542411 C00542411/01 Switzerland   Start Trial FORMER REPRESENTATIVE: BOHEST AG, CH
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.